
H-ras Oncogene Mutation and Human Papillomavirus Infection in Oral Carcinomas
Jennifer A. Anderson, MD;
Jonathan C. Irish, MD, MS, FRCSC;
C. Margaret McLachlin, MD, FRCPC;
Bo Y. Ngan, MD, PhD, FRCPC
Arch Otolaryngol Head Neck Surg. 1994;120(7):755-760.
Abstract
 |  |
Objective Previous in vitro studies have demonstrated that transfection of an activated ras gene induces malignant transformation in epithelial cell lines infected with the human papillomavirus (HPV). The results of these studies support the hypothesis that HPV may co-operate with an activated ras gene in epithelial tumor carcinogenesis. To test this hypothesis in head and neck cancers, we screened 35 oral carcinomas for the presence of HPV DNA and for a mutated H-ras gene.
Design The design of the study was a screening survey type. Twenty-seven oral squamous cell carcinomas and eight verrucous carcinomas were analyzed for the presence of HPV DNA using the polymerase chain reaction, followed by Southern blot and probe hybridization. The tumors were also screened for point mutations of the H-ras gene using the polymerase chain reaction and restriction fragment length polymorphism analysis.
Results Six (22%) of the 27 oral squamous cell carcinomas demonstrated point mutation in the H-ras gene. In addition, six tumors (22%) were positive for HPV DNA, with three tumors (11%) demonstrating both HPV DNA and H-ras gene point mutation. While the rate of simultaneous HPV infection and ras gene activation by point mutation was 11% in oral squamous cell carcinomas, 25% of oral verrucous carcinomas contained both HPV DNA and mutation in the H-ras gene.
Conclusions These results suggest a stronger association between HPV infection and activation of the H-ras gene in oral verrucous carcinomas. These results continue to confirm the multihit hypothesis of tumorigenesis and suggest that in some cases of oral cancer at least two of these events are H-ras gene mutation and HPV infection.
(Arch Otolaryngol Head Neck Surg. 1994;120:755-760)
Author Affiliations
From the Departments of Otolaryngology (Drs Anderson and Irish) and Pathology (Drs McLachlin and Ngan), University of Toronto (Ontario); the Head and Neck Program, The Toronto Hospital, and Conacher Head and Neck Cancer Research Laboratory (Dr Irish); and the Department of Pathology, Sunnybrook Health Science Centre (Dr Ngan), Toronto.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Rapamycin Prevents Early Onset of Tumorigenesis in an Oral-Specific K-ras and p53 Two-Hit Carcinogenesis Model
Raimondi et al.
Cancer Res. 2009;69:4159-4166.
ABSTRACT
| FULL TEXT
Molecular Pathogenesis of Oral Squamous Cell Carcinoma: Implications for Therapy
Choi and Myers
JDR 2008;87:14-32.
ABSTRACT
| FULL TEXT
Loss of transforming growth factor-beta type II receptor promotes metastatic head-and-neck squamous cell carcinoma.
Lu et al.
Genes Dev. 2006;20:1331-1342.
ABSTRACT
| FULL TEXT
Inducible Activation of Oncogenic K-ras Results in Tumor Formation in the Oral Cavity
Caulin et al.
Cancer Res. 2004;64:5054-5058.
ABSTRACT
| FULL TEXT
Advances in Chemoprevention of Head and Neck Cancer
Rhee et al.
The Oncologist 2004;9:302-311.
ABSTRACT
| FULL TEXT
Deregulated Cyclooxygenase-2 Expression in Oral Premalignant Tissues
Banerjee et al.
Molecular Cancer Therapeutics 2002;1:1265-1271.
ABSTRACT
| FULL TEXT
Conversion of Normal To Malignant Phenotype: Telomere Shortening, Telomerase Activation, and Genomic Instability During Immortalization of Human Oral Keratinocytes
Kang and Park
CROBM 2001;12:38-54.
ABSTRACT
| FULL TEXT
|